| Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD |
| Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015 |
| Abstract : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| ESTHER : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedID: 25973909 |
Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD (2015)
Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease
Alzheimer Disease & Associated Disorders
29 :192
Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD (2015)
Alzheimer Disease & Associated Disorders
29 :192